Crossref Cited-by Linking logo

Collect. Czech. Chem. Commun. 1964, 29, 2648-2662
https://doi.org/10.1135/cccc19642648

Amino acids and peptides. XLV. Analogues of oxytocin with O-ethyltyrosine, p-methylphenylalanine, and p-ethylphenylalanine replacing tyrosine

A. L. Zhuze, K. Jošt, E. Kasafírek and J. Rudinger

Crossref Cited-by Linking

  • Morán-Ramallal Roberto, Liz Ramón, Gotor Vicente: Enantiopure trans-3-Arylaziridine-2-carboxamides: Preparation by Bacterial Hydrolysis and Ring-Openings toward Enantiopure, Unnatural d-α-Amino Acids. J. Org. Chem. 2010, 75, 6614. <https://doi.org/10.1021/jo101377j>
  • Hruby Victor J.: Peptide Science:  Exploring the Use of Chemical Principles and Interdisciplinary Collaboration for Understanding Life Processes. J. Med. Chem. 2003, 46, 4215. <https://doi.org/10.1021/jm0303103>
  • Slaninová Jiřina, Maletínská Lenka, Vondrášek Jiří, Procházka Zdenko: Magnesium and biological activity of oxytocin analogues modified on aromatic ring of amino acid in position 2. Journal of Peptide Science 2001, 7, 413. <https://doi.org/10.1002/psc.334>
  • Procházka Zdenko, Žertová Miroslava, Slaninová Jiřina: The analogs of oxytocin and D-homoarginine vasopressin with bulky substituted phenylalanine in position 2. Lett Pept Sci 2000, 7, 179. <https://doi.org/10.1007/BF02443586>
  • Liao Subo, Shenderovich Mark D., Zhang Zhigang, Maletinska Lenka, Slaninova Jirina, Hruby Victor J.: Substitution of the Side-Chain-Constrained Amino Acids β-Methyl-2‘,6‘-Dimethyl-4‘-Methoxytyrosine in Position 2 of a Bicyclic Oxytocin Analogue Provides Unique Insights into the Bioactive Topography of Oxytocin Antagonists. J. Am. Chem. Soc. 1998, 120, 7393. <https://doi.org/10.1021/ja980848b>
  • Nyéki O., Rill A., Klsfaludy L.: RACEMIZATION-FREE PREPARATION OF Boc-Tyr(Et)-OH ACTIVE ESTERS. Organic Preparations and Procedures International 1988, 20, 96. <https://doi.org/10.1080/00304948809355874>
  • PORTER JOHN, DYKERT JOHN, RIVIER JEAN: Synthesis, resolution and characterization of ring substituted phenylalanines and tryptophans. International Journal of Peptide and Protein Research 1987, 30, 13. <https://doi.org/10.1111/j.1399-3011.1987.tb03307.x>
  • Guillon Gilles, Butlen Daniel, Cantau Bernard, Barth Tomislav, Jard Serge: Kinetic and pharmacological characterization of vasopressin membrane receptors from human kidney medulla: Relation to adenylate cyclase activation. European Journal of Pharmacology 1982, 85, 291. <https://doi.org/10.1016/0014-2999(82)90216-3>
  • Erchegi Judit, Coy David H., Nekola Mary V., Pedroza Escipion, Coy Esther J., Mezo Imre, Schally Andrew V.: LH-RH antagonists: Further analogs with ring-substituted aromatic residues. Peptides 1981, 2, 251. <https://doi.org/10.1016/S0196-9781(81)80114-3>
  • PROCEEDINGS OF THE BRITISH PHARMACOLOGICAL SOCIETY. British J Pharmacology 1981, 74. <https://doi.org/10.1111/j.1476-5381.1981.tb09971.x>
  • Lundell Edwin O., Ferger Martha F.: Synthesis and some pharmacological properties of [I-β-mercaptopropionic acid, 2-(3,5-dibromo-l-tyrosine)]-8-lysine-vasopressin. Bioorganic Chemistry 1975, 4, 377. <https://doi.org/10.1016/0045-2068(75)90048-6>
  • Bosshard Hans Rudolf, Berger Arieh: Synthesis of Optically Active, Ring‐Substituted N‐Benzyloxycarbonylphenylalanines via 2‐Benzyloxycarbonylamino‐2‐arylalkylmalonates. Helvetica Chimica Acta 1973, 56, 1838. <https://doi.org/10.1002/hlca.19730560603>
  • Jard Serge, Rajerison Rabary M, Montegut Madeleine: Inhibition des effects de l'ocytocine sur la peau et la vessie de la grenouille par l'[2-O-ethyltyrosine]-ocytocine. Biochimica et Biophysica Acta (BBA) - Biomembranes 1970, 196, 85. <https://doi.org/10.1016/0005-2736(70)90169-0>
  • Smyth D.G.: On the molecular mechanism of oxytocin action. Biochimica et Biophysica Acta (BBA) - Protein Structure 1970, 200, 395. <https://doi.org/10.1016/0005-2795(70)90182-0>
  • Krejčí Ivan, Kupková Běla, Vávra Ivan, Rudinger Josef: Actions of neurohypophysial hormone analogues on perfused isolated rat caudal artery. European Journal of Pharmacology 1970, 13, 65. <https://doi.org/10.1016/0014-2999(70)90184-6>
  • PROCEEDINGS OF THE BRITISH PHARMACOLOGICAL SOCIETY. British J Pharmacology 1970, 39. <https://doi.org/10.1111/j.1476-5381.1970.tb09568.x>
  • BISSET G. W., CLARK BARBARA J., KREJČÍ I., POLÁčEK I., RUDINGER J.: Some pharmacological properties of a synthetic oxytocin analogue [1‐N‐carbamoyl‐hemicystine‐2‐O‐methyltyrosine]‐oxytocin (carbamoyl‐methyloxytocin), an antagonist to the neurohypophysial hormones. British J Pharmacology 1970, 40, 342. <https://doi.org/10.1111/j.1476-5381.1970.tb09927.x>
  • Polácek I., Krejci I.: Effect of magnesium on the response of the rat mammary gland strip to oxytocin analogues. European Journal of Pharmacology 1969, 7, 85. <https://doi.org/10.1016/0014-2999(69)90168-X>
  • Goodman Murray, Toniolo Claudio: Conformational studies of proteins with aromatic side‐chain effects. Biopolymers 1968, 6, 1673. <https://doi.org/10.1002/bip.1968.360061202>
  • BISSET G. W., CLARK BARBARA J.: Synthetic I-N-Carbamylhemicystine-2-O-methyltyrosine-oxytocin (N-Carbamyl-O-methyl-oxytocin): a Specific Antagonist to the Actions of Oxytocin and Vasopressin on the Uterus and Mammary Gland. Nature 1968, 218, 197. <https://doi.org/10.1038/218197b0>
  • Walter Roderich, Rudinger J., Schwartz I.L.: Chemistry and structure-activity relations of the antidiuretic hormones. The American Journal of Medicine 1967, 42, 653. <https://doi.org/10.1016/0002-9343(67)90087-3>
  • Smyth Derek G.: Acetylation of Amino and Tyrosine Hydroxyl Groups. Journal of Biological Chemistry 1967, 242, 1592. <https://doi.org/10.1016/S0021-9258(18)96132-6>